PhaseV Survey Says 88 Percent of Sponsors Face Trial Reporting Delays
PhaseV released survey findings saying 88% of biopharma sponsors spend at least five weeks on critical trial reporting and data workflows. The company also described AI Conductor, a platform for trial documentation and statistical programming.